Affinia, DCM Foundation Partner to Raise Awareness of BAG3 DCM
June 3, 2025
Affinia Therapeutics, an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus gene therapies for devastating cardiovascular and neurological diseases, and